Oxnard Flootsnoot

Amylin Pharmaceuticals Stock Is Catching A Bid

I have diabetes. Byetta has brought my A1c to 6.1 from the mid 7's. 6 is normal for non-diabetics, 7 normal for diabetics. Most important, I've gotten away from the additional insulin that virtually all other medications stimulate. More insulin means more weight gain/virtually impossible to lose weight. Most diabetics (including me) are overweight. This drug is a truly miracle drug for the millions and millions of type two diabetics now and in the future. LAR is supposed to work even better.

I bought the stock because I think a great product, especially in health care, will sell well. Call me crazy. I ignore all the charts and the volatility of the stock. In my opinion, the numbers always win and the sales of this drug should go up and up and up (even if slowly). I'm in this for 3-5 years.